实现喘缓解的挑战和机遇
Elena Cojocaru1, Raluca Ioana Arcana2, Steluta Radu3
1Morpho-Functional Sciences II Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
生物疗法可以改善喘控制和减少喘恶化,但实现长期喘缓解仍然具有挑战性. 为了持续控制疾病,需要进一步的研究和标准化标准.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种全球性慢性炎症性呼吸道疾病,具有显著的发病率和医疗保健成本.
- 实现长期喘缓解仍然是一个重大的临床挑战,尽管治疗进展.
研究的目的:
- 审查喘缓解的潜力,重点关注严重喘管理中的生物药物.
- 评估长期疾病控制和缓解是否是当前疗法可以实现的目标.
主要方法:
- 临床试验,元分析和现实世界的证据的系统文献综述 (1971-2025年).
- 对针对IL-5,IL-4/IL-13,IgE和TSLP的生物疗法的分析.
- 评估的结果包括症状控制,恶化,肺功能和口服皮质类固醇使用.
主要成果:
- 生物药物显著改善了喘控制,并减少了恶化的频率.
- 完全的长期缓解 (症状,炎症,药物独立性) 尚未持续实现.
- 生物降低口服皮质类固醇的依赖,但缓解可持续性需要进一步调查.
结论:
- 生物疗法代表了严重喘治疗的重大进步,增强了症状控制和减少恶化.
- 完全缓解喘仍然是一个难以捉摸的目标,需要进一步的研究.
- 标准化缓解标准,改善患者分层和长期研究对于实现持续控制喘和缓解至关重要.
更多相关视频
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
相关概念视频
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
